LinkedIn
YouTube
Current
DefiniGEN
Life Sciences
•
East of England
•
Early Stage
•
2020
DefiniGEN creates highly predictive in vitro liver disease models, for use in preclinical research and drug development. The University of Cambridge spinout is accelerating the development of effective treatments for life-threatening liver conditions.
Looking for funding?
We’ve already helped hundreds of ambitious businesses in the UK and Ireland to accelerate their growth. If you’re looking for a minority investment partner that can provide long-term, flexible funding and support, please get in touch with our team today.
